http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108610313-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-83 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-83 |
| filingDate | 2018-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108610313-B |
| titleOfInvention | Enzyme inhibitor and application thereof |
| abstract | The invention relates to application of hydrazone compounds such aS (3R,3aR,6S, 7aS) -4-hydrazine-2-isoamyl-3, 6-dimethyl octahydrobenzofuran-3-ol, (2Z,3R,3aR, 6S,7aS) -4-hydrazine-3, 6-dimethyl-2- (3-methylbutenyl) octahydrobenzofuran-3-ol and the like aS urease inhibitors. The compound has high-efficiency inhibitory action on urease, and can be used as a novel medicament for treating gastric ulcer, duodenal ulcer and gastritis. |
| priorityDate | 2018-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.